Literature DB >> 1347060

Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends.

J A Havlik1, C R Horsburgh, B Metchock, P P Williams, S A Fann, S E Thompson.   

Abstract

To evaluate the incidence of disseminated Mycobacterium avium complex infection (DMAC) and to define the association between signs and symptoms and development of DMAC in patients with human immunodeficiency virus (HIV) infection, all cases of DMAC at Grady Memorial Hospital Infectious Disease Clinic (Atlanta) between 1985 and 1990 were reviewed, and a prospective study of the association of symptoms with DMAC was done. Between 1985 and 1990, DMAC occurred in 16% of patients with AIDS. Incidence increased from 5.7% in 1985-1988 to 23.3% in 1989-1990 (P less than .001). Median time from AIDS diagnosis to diagnosis of DMAC increased from 4.5 months in 1985-1988 to 8 months in 1989-1990 (P less than .02). In the prospective study, DMAC was seen only in persons with a CD4+ count less than 100 cells/mm3 and was associated with fever (P less than .03), anemia (P less than .001), weight loss (P less than .01), diarrhea (P less than .01), and elevated alkaline phosphatase (P less than .01). It is recommended that all such HIV-infected persons have mycobacterial blood cultures done.

Entities:  

Mesh:

Year:  1992        PMID: 1347060     DOI: 10.1093/infdis/165.3.577

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.

Authors:  L Steele-Moore; K Stark; W J Holloway
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  Etiology and evaluation of diarrhea in AIDS:a global perspective at the millennium.

Authors:  C Mel Wilcox
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

Review 3.  Update on detection of bacteremia and fungemia.

Authors:  L G Reimer; M L Wilson; M P Weinstein
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

4.  The usefulness of PCR assay in diagnosing disseminated mycobacterial infection in AIDS patients.

Authors:  L Gazzola; F Zanini; P Zerbi; F Franzetti; A Gori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-13       Impact factor: 3.267

Review 5.  Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis.

Authors:  A Pozniak; M R Nelson
Journal:  Genitourin Med       Date:  1996-08

Review 6.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

7.  Duodenitis, Diarrhea, and Death in a Patient with AIDS.

Authors:  Anas Gremida; Davika Kapuria; Marissa A Tafoya; Archana Kaza; Denis McCarthy
Journal:  Dig Dis Sci       Date:  2018-11       Impact factor: 3.199

8.  Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice.

Authors:  T Lazard; C Perronne; Y Cohen; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

9.  Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245.

Authors:  J Bauer; A B Andersen; D Askgaard; S B Giese; B Larsen
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques.

Authors:  D A Revicki; K N Simpson; A W Wu; R L LaVallee
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.